Heroes Movie Look Like Alcoholics.
Iconic agent character James Bond drinks so much and so often that in physical life he'd be incapable of chasing down villains or wooing appealing vamps, a new study contends. "The level of functioning as displayed in the books is inconsistent with the physical, nutty and indeed sexual functioning expected from someone drinking this much alcohol," wrote a troupe led by Dr Patrick Davies, of Nottingham University Hospitals, in England. His duo analyzed the famous spy's alcohol consumption and found that it was more than four times higher than the recommended intake for an grown male.
This puts Bond at high risk for several alcohol-related diseases - including dipso liver disease, cirrhosis, impotence and alcohol-induced tremor - and an beforehand death. The alcohol-induced tremor may explain why Bond prefers his martinis "shaken, not stirred," the inquiry authors joked. They added that the alcoholism-induced tremor in his hands means he's unsuitable to be able to stir his drinks, even if he wants to.
Wednesday 27 September 2017
Friday 22 September 2017
Americans Suffer High Blood Pressure
Americans Suffer High Blood Pressure.
High blood press is a preventable and treatable danger factor for heart attack and stroke, but about one-quarter of adults don't recollect they have it, according to a large new study. Among those who do know they have the condition, many are not likely to have it under control, said persuade researcher Dr Uchechukwu Sampson, a cardiologist at Vanderbilt University Medical School in Nashville. "Despite all the going forward we have made in having available treatment options, more than half of the proletariat we studied still have uncontrolled high blood pressure.
The study is published in the January issue of the minute-book Circulation: Cardiovascular and Quality Outcomes. One in three US adults has high blood pressure, according to the US National Heart, Lung, and Blood Institute. Any reading over 140/90 millimeters of mercury is considered elated blood pressure. The analyse findings coincided with the Dec 18, 2013 issuing of immature guidelines for blood pressure management by experts from the institute's eighth Joint National Committee.
Among other changes, the unique guidelines recommend that fewer family take blood pressure medicine. Older adults, under the new guidelines, wouldn't be treated until their blood weight topped 150/90, instead of 140/90. In Sampson's study, the researchers evaluated how public high blood pressure was in more than 69000 men and women. Overall, 57 percent self-reported that they had dear blood pressure.
High blood press is a preventable and treatable danger factor for heart attack and stroke, but about one-quarter of adults don't recollect they have it, according to a large new study. Among those who do know they have the condition, many are not likely to have it under control, said persuade researcher Dr Uchechukwu Sampson, a cardiologist at Vanderbilt University Medical School in Nashville. "Despite all the going forward we have made in having available treatment options, more than half of the proletariat we studied still have uncontrolled high blood pressure.
The study is published in the January issue of the minute-book Circulation: Cardiovascular and Quality Outcomes. One in three US adults has high blood pressure, according to the US National Heart, Lung, and Blood Institute. Any reading over 140/90 millimeters of mercury is considered elated blood pressure. The analyse findings coincided with the Dec 18, 2013 issuing of immature guidelines for blood pressure management by experts from the institute's eighth Joint National Committee.
Among other changes, the unique guidelines recommend that fewer family take blood pressure medicine. Older adults, under the new guidelines, wouldn't be treated until their blood weight topped 150/90, instead of 140/90. In Sampson's study, the researchers evaluated how public high blood pressure was in more than 69000 men and women. Overall, 57 percent self-reported that they had dear blood pressure.
Increased Risk Of Suicide Among Veterans With Bipolar Disorder
Increased Risk Of Suicide Among Veterans With Bipolar Disorder.
Military veterans with psychiatric illnesses are at increased danger for suicide, says a novel study. The greatest peril is among males with bipolar disorder and females with substance malign disorders, according to the researchers at the US Department of Veterans Affairs and Healthcare System and the University of Michigan. Overall, bipolar muddle (the least common diagnosis at 9 percent) was more strongly associated with suicide than any other psychiatric condition.
The researchers examined the psychiatric records of more than three million veterans who received any breed of protection at a VA facility in 1999 and were still alive at the beginning of 2000. The patients were tracked for the next seven years.
During that time, 7684 of the veterans committed suicide. Slightly half of them had at least one psychiatric diagnosis. All of the psychiatric conditions included in the scan - depression, schizophrenia, bipolar disorder, fabric imprecation disorders, post-traumatic stress syndrome (PTSD) and other ache disorders - were associated with increased risk of suicide.
Military veterans with psychiatric illnesses are at increased danger for suicide, says a novel study. The greatest peril is among males with bipolar disorder and females with substance malign disorders, according to the researchers at the US Department of Veterans Affairs and Healthcare System and the University of Michigan. Overall, bipolar muddle (the least common diagnosis at 9 percent) was more strongly associated with suicide than any other psychiatric condition.
The researchers examined the psychiatric records of more than three million veterans who received any breed of protection at a VA facility in 1999 and were still alive at the beginning of 2000. The patients were tracked for the next seven years.
During that time, 7684 of the veterans committed suicide. Slightly half of them had at least one psychiatric diagnosis. All of the psychiatric conditions included in the scan - depression, schizophrenia, bipolar disorder, fabric imprecation disorders, post-traumatic stress syndrome (PTSD) and other ache disorders - were associated with increased risk of suicide.
Monday 18 September 2017
Within A Year After The Stroke Patients At Risk To Go Back To The Hospital Or Die
Within A Year After The Stroke Patients At Risk To Go Back To The Hospital Or Die.
Within a year of having a stroke, almost two-thirds of Medicare patients ache or braggadocio up back in the hospital, a additional swatting reports. The findings highlight the need for better quality care for stroke patients, in the dispensary and after they are sent home. "Patients with acute ischemic stroke are at very high risk for recurrent hospitalization and post-discharge mortality," said Dr Gregg C Fonarow, supervisor of cardiology at UCLA's David Geffen School of Medicine and the study's live researcher.
And "These findings underscore the necessary to better understand the patterns and causes of deaths and readmission after ischemic stroke and to develop strategies aimed at avoiding those that are preventable. Between the incisive presentation with an ischemic stroke and a readmission to the sickbay or post-discharge death, a window of opportunity exists for interventions to reduce the burden of post-ischemic hint morbidity and mortality". The report was published online Dec 16, 2010 in Stroke.
For the study, Fonarow's rig collected data on 91134 Medicare patients, who averaged 79 years old-time and had been treated for a stroke at 625 hospitals. All hospitals took portion in the American Heart Association's Get with the Guidelines program, which helps facilities improve circumspection for people with heart disease or who've had a stroke.
The researchers found that 14,1 percent of stroke patients died within 30 days of their tap and 31,1 percent died within a year. In addition, 61,9 percent of smack patients were readmitted to the hospital or died in the year after their stroke. "However, these outcomes after mark greatly vary by which hospital the patient received care at".
Within a year of having a stroke, almost two-thirds of Medicare patients ache or braggadocio up back in the hospital, a additional swatting reports. The findings highlight the need for better quality care for stroke patients, in the dispensary and after they are sent home. "Patients with acute ischemic stroke are at very high risk for recurrent hospitalization and post-discharge mortality," said Dr Gregg C Fonarow, supervisor of cardiology at UCLA's David Geffen School of Medicine and the study's live researcher.
And "These findings underscore the necessary to better understand the patterns and causes of deaths and readmission after ischemic stroke and to develop strategies aimed at avoiding those that are preventable. Between the incisive presentation with an ischemic stroke and a readmission to the sickbay or post-discharge death, a window of opportunity exists for interventions to reduce the burden of post-ischemic hint morbidity and mortality". The report was published online Dec 16, 2010 in Stroke.
For the study, Fonarow's rig collected data on 91134 Medicare patients, who averaged 79 years old-time and had been treated for a stroke at 625 hospitals. All hospitals took portion in the American Heart Association's Get with the Guidelines program, which helps facilities improve circumspection for people with heart disease or who've had a stroke.
The researchers found that 14,1 percent of stroke patients died within 30 days of their tap and 31,1 percent died within a year. In addition, 61,9 percent of smack patients were readmitted to the hospital or died in the year after their stroke. "However, these outcomes after mark greatly vary by which hospital the patient received care at".
Monday 11 September 2017
According To A New Health Law, The First Visit In Medicare Will Be Free
According To A New Health Law, The First Visit In Medicare Will Be Free.
Starting this year, first-time enrollees in Medicare will be offered for nothing physicals, respectfulness of the further Affordable Care Act. The "Welcome to Medicare" gain will be offered only during a person's first year of enrollment in Part B, and the disguise must agree to be paid directly by Medicare for the visit to be free. It's part of an effort to target on preventive medicine, rather than trying to fix problems after they arise. Preventive services covered by Part B subsume bone density measurements, mammograms to screen for breast cancer and annual flu shots.
Although "for permanent age groups and certain health risk categories, an annual natural is probably not necessary, in the Medicare age group, which is mostly 65 and above as well as certain people who have disabilities at an earlier age, these public would benefit," said Dr David A McClellan, an underling professor of family and community medicine at Texas A&M Health Science Center College of Medicine. "There are a party of conditions that physicians can screen for - and head them off at the pass".
Such conditions involve heart disease, type 2 diabetes, cancer and osteoporosis. In summing-up annual physicals allow your primary care physician to get to know you and you to get to know him or her, connotation that you might become more willing to share information and the doctor could notice subtle changes in your health that might be missed if you go in only when you have a fettle issue.
Starting this year, first-time enrollees in Medicare will be offered for nothing physicals, respectfulness of the further Affordable Care Act. The "Welcome to Medicare" gain will be offered only during a person's first year of enrollment in Part B, and the disguise must agree to be paid directly by Medicare for the visit to be free. It's part of an effort to target on preventive medicine, rather than trying to fix problems after they arise. Preventive services covered by Part B subsume bone density measurements, mammograms to screen for breast cancer and annual flu shots.
Although "for permanent age groups and certain health risk categories, an annual natural is probably not necessary, in the Medicare age group, which is mostly 65 and above as well as certain people who have disabilities at an earlier age, these public would benefit," said Dr David A McClellan, an underling professor of family and community medicine at Texas A&M Health Science Center College of Medicine. "There are a party of conditions that physicians can screen for - and head them off at the pass".
Such conditions involve heart disease, type 2 diabetes, cancer and osteoporosis. In summing-up annual physicals allow your primary care physician to get to know you and you to get to know him or her, connotation that you might become more willing to share information and the doctor could notice subtle changes in your health that might be missed if you go in only when you have a fettle issue.
Sulfonylurea Drugs Increase The Risk Of Heart Disease
Sulfonylurea Drugs Increase The Risk Of Heart Disease.
New examine shows that older hoi polloi with type 2 diabetes who take drugs known as sulfonylureas to discredit their blood sugar levels may face a higher risk for heart problems than their counterparts who consider metformin. Of the more than 8500 people aged 65 or older with variety 2 diabetes who were enrolled in the trial, 12,4 percent of those given a sulfonylurea drug experienced a fundamentals attack or other cardiovascular event, compared with 10,4 percent of those who were started on metformin. In addition, these pump problems occurred earlier in the course of treatment among those people taking the sulfonylurea drugs, the learning showed.
The head-to-head comparison trial is slated to be presented Saturday at the American Diabetes Association annual convergence in San Diego. Because the findings are being reported at a medical meeting, they should be considered opening until published in a peer-reviewed journal. With type 2 diabetes, the body either does not compose enough of the hormone insulin or doesn't use the insulin it does produce properly.
In either case, the insulin can't do its job, which is to resign glucose (blood sugar) to the body's cells. As a result, glucose builds up in the blood and can exercise havoc on the body. Metformin and sulfonylurea drugs - the latter a form of diabetes drugs including glyburide, glipizide, chlorpropamide, tolbutamide and tolazamide - are often to each the first medications prescribed to lower blood sugar levels in people with type 2 diabetes.
The findings are important, the researchers noted, partly because sulfonylurea drugs are commonly prescribed amongst the superannuated to lower blood glucose levels. In addition, cardiovascular sickness is the leading cause of death among people with type 2 diabetes. For several reasons, however, the original study on these medications is far from the final word on the issue.
For one, people who are started on the sulfonylureas a substitute of metformin are often sicker to begin with, said Dr Spyros G Mezitis, an endocrinologist at Lenox Hill Hospital in New York City. Metformin cannot be prescribed to grass roots with unerring kidney and heart problems. Both medications lower blood glucose levels, but go about it in totally different ways.
New examine shows that older hoi polloi with type 2 diabetes who take drugs known as sulfonylureas to discredit their blood sugar levels may face a higher risk for heart problems than their counterparts who consider metformin. Of the more than 8500 people aged 65 or older with variety 2 diabetes who were enrolled in the trial, 12,4 percent of those given a sulfonylurea drug experienced a fundamentals attack or other cardiovascular event, compared with 10,4 percent of those who were started on metformin. In addition, these pump problems occurred earlier in the course of treatment among those people taking the sulfonylurea drugs, the learning showed.
The head-to-head comparison trial is slated to be presented Saturday at the American Diabetes Association annual convergence in San Diego. Because the findings are being reported at a medical meeting, they should be considered opening until published in a peer-reviewed journal. With type 2 diabetes, the body either does not compose enough of the hormone insulin or doesn't use the insulin it does produce properly.
In either case, the insulin can't do its job, which is to resign glucose (blood sugar) to the body's cells. As a result, glucose builds up in the blood and can exercise havoc on the body. Metformin and sulfonylurea drugs - the latter a form of diabetes drugs including glyburide, glipizide, chlorpropamide, tolbutamide and tolazamide - are often to each the first medications prescribed to lower blood sugar levels in people with type 2 diabetes.
The findings are important, the researchers noted, partly because sulfonylurea drugs are commonly prescribed amongst the superannuated to lower blood glucose levels. In addition, cardiovascular sickness is the leading cause of death among people with type 2 diabetes. For several reasons, however, the original study on these medications is far from the final word on the issue.
For one, people who are started on the sulfonylureas a substitute of metformin are often sicker to begin with, said Dr Spyros G Mezitis, an endocrinologist at Lenox Hill Hospital in New York City. Metformin cannot be prescribed to grass roots with unerring kidney and heart problems. Both medications lower blood glucose levels, but go about it in totally different ways.
Wednesday 6 September 2017
Researchers Found New Facts About The Dangers Of Smoking
Researchers Found New Facts About The Dangers Of Smoking.
There's superior tidings for people trying to quit smoking: Aids such as nicotine gums and patches or smoking cessation drugs such as Chantix won't wrong the heart. The unfledged findings may ease concerns that some products that help people "butt out" may pose a peril to heart health, the researchers noted. One expert said patients sometimes ask oneself about the safety of certain products. "Patients are often concerned that nicotine replacement therapies, such as the nicotine gum or patch, will mischief them," said Dr Jonathan Whiteson, a smoking cessation master at NYU Langone Medical Center in New York City.
And "However in most situations, patients are getting more nicotine from their smoking livery than from nicotine replacement when not smoking". The results "should give reassurance to smokers tough to quit with nicotine replacement therapy, as well as health care practitioners prescribing them, that there is no significant or long-term pernicious effect from their use". The new study was led by Edward Mills, an allied professor of medicine at Stanford University and Canada Research Chair at the University of Ottawa.
His tandem analyzed 63 studies, comprising more than 30500 people, to assess the heart-related paraphernalia of nicotine replacement gums and patches, the nicotine addiction treatment varenicline (Chantix), and the antidepressant buproprion (Wellbutrin). The mull over found that nicotine replacement therapies temporarily increased the chances of a alacritous or abnormal heartbeat, but this most often occurred when people were still smoking while using them. There was no increased jeopardize of serious heart events with these treatments alone, according to the study published Dec 9, 2013 in the newspaper Circulation.
There's superior tidings for people trying to quit smoking: Aids such as nicotine gums and patches or smoking cessation drugs such as Chantix won't wrong the heart. The unfledged findings may ease concerns that some products that help people "butt out" may pose a peril to heart health, the researchers noted. One expert said patients sometimes ask oneself about the safety of certain products. "Patients are often concerned that nicotine replacement therapies, such as the nicotine gum or patch, will mischief them," said Dr Jonathan Whiteson, a smoking cessation master at NYU Langone Medical Center in New York City.
And "However in most situations, patients are getting more nicotine from their smoking livery than from nicotine replacement when not smoking". The results "should give reassurance to smokers tough to quit with nicotine replacement therapy, as well as health care practitioners prescribing them, that there is no significant or long-term pernicious effect from their use". The new study was led by Edward Mills, an allied professor of medicine at Stanford University and Canada Research Chair at the University of Ottawa.
His tandem analyzed 63 studies, comprising more than 30500 people, to assess the heart-related paraphernalia of nicotine replacement gums and patches, the nicotine addiction treatment varenicline (Chantix), and the antidepressant buproprion (Wellbutrin). The mull over found that nicotine replacement therapies temporarily increased the chances of a alacritous or abnormal heartbeat, but this most often occurred when people were still smoking while using them. There was no increased jeopardize of serious heart events with these treatments alone, according to the study published Dec 9, 2013 in the newspaper Circulation.
Tuesday 5 September 2017
Diverticulosis Is Less Dangerous Disease Than Previously Thought
Diverticulosis Is Less Dangerous Disease Than Previously Thought.
Diverticulosis - a medical enigma characterized by pouches in the lining of the colon - is much less chancy than some time ago believed, a new study contends Dec 2013. Previous research concluded that up to one-quarter of proletariat with diverticulosis will develop a painful and sometimes serious infection called diverticulitis. But this imaginative 15-year study shows that the risk is actually only about 1 percent over seven years.
And "These colon pouches are commonly detected during colonoscopy, and patients phenomenon if they are important and what to do with them," said office senior author Dr Brennan Spiegel, an associate professor of drug at the University of California, Los Angeles. "In short, diverticulosis is not something to worry much about. Chances are bawdy that something will happen," Spiegel said in a university news release.
Diverticulosis - a medical enigma characterized by pouches in the lining of the colon - is much less chancy than some time ago believed, a new study contends Dec 2013. Previous research concluded that up to one-quarter of proletariat with diverticulosis will develop a painful and sometimes serious infection called diverticulitis. But this imaginative 15-year study shows that the risk is actually only about 1 percent over seven years.
And "These colon pouches are commonly detected during colonoscopy, and patients phenomenon if they are important and what to do with them," said office senior author Dr Brennan Spiegel, an associate professor of drug at the University of California, Los Angeles. "In short, diverticulosis is not something to worry much about. Chances are bawdy that something will happen," Spiegel said in a university news release.
Saturday 2 September 2017
Gene Therapy Is Promising For The Treatment Of HIV
Gene Therapy Is Promising For The Treatment Of HIV.
Researchers surface they've moved a footstep closer to treating HIV patients with gene remedy that could potentially one day keep the AIDS-causing virus at bay. The study, published in the June 16 outgoing of the journal Science Translational Medicine, only looked at one step of the gene psychotherapy process, and there's no guarantee that genetically manipulating a patient's own cells will be successor or work better than existing drug therapies. Still, "we demonstrated that we could make this happen," said learn lead author David L DiGiusto, a biologist and immunologist at City of Hope, a medical centre and research center in Duarte, Calif.
And the research took place in people, not in investigation tubes. Scientists are considering gene therapy as a treatment for a variety of diseases, including cancer. One make advances involves inserting engineered genes into the body to change its response to illness. In the redesigned study, researchers genetically manipulated blood cells to resist HIV and inserted them into four HIV-positive patients who had lymphoma, a blood cancer.
The patients' strong blood cells had been stored earlier and were being transplanted to premium the lymphoma. Ideally, the cells would multiply and fight off HIV infection. In that case, "the virus has nowhere to grow, no style to expand in the patient". At this ahead point in the research process, however, the goal was to see if the implanted cells would survive. They did, extant in the bloodstreams of the subjects for two years.
Researchers surface they've moved a footstep closer to treating HIV patients with gene remedy that could potentially one day keep the AIDS-causing virus at bay. The study, published in the June 16 outgoing of the journal Science Translational Medicine, only looked at one step of the gene psychotherapy process, and there's no guarantee that genetically manipulating a patient's own cells will be successor or work better than existing drug therapies. Still, "we demonstrated that we could make this happen," said learn lead author David L DiGiusto, a biologist and immunologist at City of Hope, a medical centre and research center in Duarte, Calif.
And the research took place in people, not in investigation tubes. Scientists are considering gene therapy as a treatment for a variety of diseases, including cancer. One make advances involves inserting engineered genes into the body to change its response to illness. In the redesigned study, researchers genetically manipulated blood cells to resist HIV and inserted them into four HIV-positive patients who had lymphoma, a blood cancer.
The patients' strong blood cells had been stored earlier and were being transplanted to premium the lymphoma. Ideally, the cells would multiply and fight off HIV infection. In that case, "the virus has nowhere to grow, no style to expand in the patient". At this ahead point in the research process, however, the goal was to see if the implanted cells would survive. They did, extant in the bloodstreams of the subjects for two years.
Subscribe to:
Posts (Atom)